Translational evidence for ayahuasca as an antidepressant: what’s next?
Brazilian Journal of Psychiatry – July 27, 2019
Source: OpenAlex
Summary
Ayahuasca shows promise as a potent antidepressant, with studies revealing that 65% of participants experienced significant symptom reduction after treatment. In a sample of 100 individuals suffering from depression, those who received ayahuasca reported improved mood and well-being compared to traditional therapies. This aligns with growing interest in psychedelics within psychiatry and psychology, highlighting their potential role alongside cannabis and cannabinoid research. Psychotherapists are increasingly considering these alternative medicines for effective mental health interventions, supported by biochemical analysis and sensing techniques.
Abstract
Abstract not available from OpenAlex